title: [Clinical importance of changes in thrombocytic hemostasis in lung cancer].
abstract: Clinico-laboratory examinations of 86 patients have shown that lung cancer develops against the background of activation of the thrombocytic link of hemostasis which manifested itself in thrombocytosis, greater degree of destruction of the lysosomal membranes, lower energy resources of the cells, their tendency to slow and little reversible aggregation. The authors consider that the indicators of the ADP-induced aggregation of thrombocytes may be used for prognosis of postoperative pyo-inflammatory and thromboembolic complications. HBO is good for correction of alterations in the thrombocytic link of hemostasis in lung cancer and its suppurative complications.
mesh_terms: D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000502:physiology*; D005260:Female; D006487:Hemostasis; D006801:Humans; D006931:Hyperbaric Oxygenation; D008175:Lung Neoplasms / Q000097:blood* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000097:blood; D010974:Platelet Aggregation; D010976:Platelet Count; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000097:blood / Q000175:diagnosis / Q000628:therapy
vernacular_title: Klinicheskoe znachenie izmeneniĭ trombotsitarnogo gemostaza pri rake legkogo.